“…Steroid hormones can inhibit both, nitric oxide and cGMP production in the uterus (Yallampali et al, 1994). Furthermore, production of nitric oxide or cGMP by cultured ovarian cells can be stimulated by LH-RH, LH and FSH (Nitray et al, 1992;McGee et al, 1997;Kaipia and Hsueh, 1997;Tabruae et al, 1997), GH, prolactin , oxytocin (OT, Sirotkin et al, 1995;Sirotkin, 1996;Sirotkin et al, 1996), but not vasopressin or vasotocin (Nitray et al, 1992;Sirotkin et al, 1995), by steroid hormones (Sirotkin and Nitray, 1993;Sirotkin et al, 1995), melatonin (Sirotkin, 1994), tumor necrosis factor alpha (Brunswig-Spickenheier and Mukhopadhyay, 1997), interleukin-1 (Kaipia and Hsueh, 1997), atrial natriuretic factor (Pandey et al, 1987), and calcium ionophore (Danisova et al, 1995). Furthermore, cGMP analogues or activators of endogenous cGMP production are able to activate progesterone (P) and estradiol secretion (LaPolt and Hong, 1995;Masuda et al, 1997) and suppress apoptosis in ovarian cells (Kaipia and Hsueh, 1997;McGee et al, 1997).…”